Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · IEX Real-Time Price · USD
3.010
-0.050 (-1.63%)
At close: Jun 18, 2024, 4:00 PM
3.030
+0.020 (0.66%)
After-hours: Jun 18, 2024, 5:04 PM EDT

Arbutus Biopharma Market Cap

Arbutus Biopharma has a market cap or net worth of $568.04 million as of June 18, 2024. Its market cap has increased by 37.87% in one year.

Market Cap
568.04M
Enterprise Value
445.20M
1-Year Change
37.87%
Ranking
Category
Stock Price
$3.01

Market Cap Chart

Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $568.04M, an increase of 1,095.87%. That is a compound annual growth rate of 18.71%.

History

DateMarket Cap% Change
Jun 17, 2024577.50M-2.55%
Jun 14, 2024592.60M-0.62%
Jun 13, 2024596.30M-2.77%
Jun 12, 2024613.30M2.20%
Jun 11, 2024600.10M1.27%
Jun 10, 2024592.60M-1.87%
Jun 7, 2024603.90M-4.19%
Jun 6, 2024630.30M-7.99%
Jun 5, 2024685.00M8.68%
Jun 4, 2024630.30M-2.34%
Jun 3, 2024645.40M1.78%
May 31, 2024634.10M1.21%
May 30, 2024626.50M-1.20%
May 29, 2024634.10M0.30%
May 28, 2024632.20M1.82%
May 24, 2024620.90M0.31%
May 23, 2024619.00M-3.81%
May 22, 2024643.50M6.22%
May 21, 2024605.80M4.56%
May 20, 2024579.40M3.02%
May 17, 2024562.40M3.12%
May 16, 2024545.40M2.85%
May 15, 2024530.30M-1.74%
May 14, 2024539.70M-1.05%
May 13, 2024545.40M0.35%
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Zentalis Pharmaceuticals 603.61M
Surmodics 597.64M
National Research 597.53M
REGENXBIO 594.52M
Fulgent Genetics 590.13M
Pharming Group 571.75M
iTeos Therapeutics 571.46M
Applied Therapeutics 569.05M
Market Cap Rankings